Endothelial protein C receptor

PROCR
Identifiers
AliasesPROCR, CCCA, CCD41, EPCR, protein C receptor
External IDsOMIM: 600646; MGI: 104596; GeneCards: PROCR
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

10544

19124

Ensembl

ENSG00000101000

ENSMUSG00000027611

UniProt

Q9UNN8

Q64695

RefSeq (mRNA)

NM_006404

NM_011171

RefSeq (protein)

NP_006395

NP_035301

Location (UCSC)Chr 20: 35.17 – 35.22 MbChr 2: 155.59 – 155.6 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Endothelial protein C receptor (EPCR) also known as activated protein C receptor (APC receptor) is a protein that in humans is encoded by the PROCR gene. PROCR has also recently been designated CD201 (cluster of differentiation 201).

EPCR is a transmembrane glycoprotein receptor that plays a crucial role in regulation of blood coagulation, inflammation, and vascular integrity. Its ability to enhance the anticoagulant activity of protein C, modulate inflammatory responses, and maintain endothelial barrier function highlights its importance in homeostasis maintenance.

The endothelial protein C receptor (EPCR) is a transmembrane glycoprotein which is encoded by the PROCR gene. EPCR is also known as the activated protein C receptor or CD201. EPCR was originally known for its role in the protein C anticoagulant pathway. In this pathway, EPCR helps regulate the formation of blood clots. It is expressed on endothelial cells which line the blood vessels. Research has shown that EPCR can also participate in the regulation of inflammation, survival of endothelial cells, vascular permeability and immune responses.

It functions as a receptor for protein C and activated protein C (APC) EPCR increases the efficiency of protein C activation by positioning protein C near the thrombin-thrombomodulin complex onto the endothelial cells. Once formed, APC decreases the coagulation by inactivating factor Va and factor VIIIa. APC initiates cytoprotective signaling by cleaving protease-activated receptor 1 (PAR1) which results in anti-inflammatory, preventing programmed cell death, and protecting the endothelial barrier.

EPCR is also important in a clinical sense, in infectious and inflammatory diseases. In severe Plasmodium falciparum malaria, the parasite proteins that are expressed on the infected red blood cells bind to EPCR and initiate sequestration in the small blood vessels. This can interfere with the protein C pathway and help with the endothelial cells becoming activated, inflammation, abnormalities in the coagulation cascade and vascular leakage.